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Abstract
Background: Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour that is the most common
cause of cancer-related deaths in children. Increasing availability of genomic data over the last decade had resulted in
improvement of human subtype classification methods, and the parallel development of MB mouse models towards
identification of subtype-specific disease origins and signaling pathways. Despite these advances, MB classification
schemes remained inadequate for personalized prediction of MB subtypes for individual patient samples and across
model systems. To address this issue, we developed the Medullo-Model to Subtypes (MM2S) classifier, a new method
enabling classification of individual gene expression profiles from MB samples (patient samples, mouse models, and
cell lines) against well-established molecular subtypes [Genomics 106:96-106, 2015]. We demonstrated the accuracy
and flexibility of MM2S in the largest meta-analysis of human patients and mouse models to date. Here, we present
a new functional package that provides an easy-to-use and fully documented implementation of the MM2S method,
with additional functionalities that allow users to obtain graphical and tabular summaries of MB subtype predictions
for single samples and across sample replicates. The flexibility of the MM2S package promotes incorporation of MB
predictions into large Medulloblastoma-driven analysis pipelines, making this tool suitable for use by researchers.
Results: The MM2S package is applied in two case studies involving human primary patient samples, as well as sample
replicates of the GTML mouse model. We highlight functions that are of use for species-specific MB classification, across
individual samples and sample replicates. We emphasize on the range of functions that can be used to derive both
singular and meta-centric views of MB predictions, across samples and across MB subtypes.
Conclusions: Our MM2S package can be used to generate predictions without having to rely on an external web server
or additional sources. Our open-source package facilitates and extends the MM2S algorithm in diverse computational and
bioinformatics contexts. The package is available on CRAN, at the following URL: https://cran.r-project.org/web/packages/
MM2S/, as well as on Github at the following URLs: https://github.com/DGendoo and https://github.com/bhklab.
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Background
Molecular subtyping is instrumental towards selection of
model systems for fundamental research in tumour
pathogenesis, and for clinical assessment of patients. To
date, four molecular subtypes of Medulloblastoma (MB)
have been established: SHH, WNT, Group3, Group4.
The Group3 and Group4 MB subtypes are the least char-
acterized, most aggressive, and have the poorest prognosis
[1]. Model systems, including MB cell lines and genetically
engineered mouse models [2], are being continually devel-
oped with the goal of studying MB subtype disease origins
and signaling pathways. However, understanding the
degree to which these model systems recapitulate Human
MB subtypes remains the greatest challenge, especially for
poorly characterized subtypes. In particular, many of the
developed models have been predicted belong to the SHH
subtype, with few models identified as recapitulating the
Group3 or WNT phenotypes [3].
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The lack of a versatile and personalized classification
system hinders effective assessment of MB patients, and
fundamental research into subtype-specific pathogenesis
using model systems. To address these issues we devel-
oped a novel Medullo-Model To Subtypes (MM2S)
classifier that matches individual gene expression profiles
from MB samples against well-established molecular
subtypes [4]. The MM2S algorithm is advantageous over
existing MB-subtyping algorithms [3] by providing single-
sample classifications while eradicating the need for a
reference sample (e.g., human cerebellum) or sample
replicates to generate predictions. MM2S design relies on
a flexible, systems-based approach that makes it extensible
and easily applicable across MB patients, human cell lines,
and mouse models. We previously demonstrated MM2S
extensibility and effectiveness across the largest meta-
analysis of human MB patients, cell lines, and mouse
samples to date [4]. In order to provide the scientific
community with an easy-to-use and fully documented
implementation of our flexible MB classifier we devel-
oped a new R package, MM2S, which implements the
MM2S algorithm across human MB patients and model
systems.
Implementation
Training and development of the MM2S classification
algorithm and hyperparameters has been previously
described in detail [4], and the overall analysis design is
provided in Additional file 1: Figure S1. Briefly, MM2S is
trained on a set of 347 normal and tumor human MB
samples pertaining to the SHH, Group3, and Group4 MB
subtypes. Single-sample Gene Set Enrichment Analysis
(ssGSEA) is conducted on mouse and human expression
profiles using species-specific GMT files that were gener-
ated from common Gene Ontology Biological Processes
(GO BP) genesets between human and mouse. Following
ssGSEA, an ssGSEA-ranked matrix is generated from
subtype-discriminative genesets by ranking genesets in
descending order of their ES scores for each sample. To
account for platform differences across test samples, we
introduced an additional step that filters for common
genesets between the test sample and human, prior to
generating ssGSEA-ranked matrices for predictions. A
k-nearest neighbor (KNN) classification uses the
ssGSEA-ranked matrix and the 5 nearest neighbors of
a given sample to make subtype predictions.
We have developed two main functions (MM2S.human
and MM2S.mouse) that apply the MM2S algorithm
towards human primary tumours and cell lines, and MB
mouse models, respectively (Fig. 1). We ensured a stan-
dardized output format that facilitates graphical rendering
of the MM2S predictions in a variety of contexts (Fig. 1).
We have introduced multiple functions that combine
both sample-centric and subtype-centric views of the
MM2S output. The sample-centric views (using the
functions PredictionsHeatmap, PredictionsBarplot
and PCARender) are easily interpretable and facilitate
association of a particular Human MB subtype to
normalized gene expression values for a given sample.
High-confidence predictions (≥80 % of votes) are in-
dicative of a corresponding human subtype, and lower
predictions indicate an intermediate genotype. Where
a large number of sample replicates are tested simul-
taneously, subtype-centric views (using the functions
PredictionsDistributionPie and PredictionsDistribu-
tionBoxplot) indicate the majority subtype and con-
sensus predictions across all replicates.
Results and discussion
We have selected some examples from our previous
analysis [4], to demonstrate the data reproducibility and
improved data rendering capabilities of the MM2S package
compared to the server implementation. MM2S is applied
in two case studies involving human primary patient sam-
ples and sample replicates of the GTML mouse model.
The package and underlying functions we present here
are fully documented, easy to install and to incorporate
into larger Medulloblastoma-driven analysis pipelines
(Additional file 2: Data 1, Additional file 3: Data 2).
MM2S Prediction of Human MB Subtypes for Patient
Tumour Samples
We tested here MM2S on a dataset of human patient
samples from the Gene Expression Omnibus (GEO), for
which subtypes are already known. The GSE37418
dataset contains 76 primary patient samples including
WNT (n = 8), SHH (n = 10), Group3 (n = 16) and
Group4 (n = 39), and outlier samples not pertaining to the
major MB subgroups (n = 3). Using the MM2S.human
function, MM2S accurately predicts patient samples
across well-studied MB subtypes (WNT and SHH, 100 %
accuracy), as well as the lesser-characterized Group3
(87.5 %) and Group4 (79.4 %) (Additional file 4: Table S1,
Additional file 5: Table S2). The full code is provided in
package vignette and in Additional file 2: Data 1. We also
provide additional examples of how to process the data
from NCBI GEO prior to using the MM2S.human
function in Additional file 3: Data 2.
MM2S Prediction of Human MB Subtypes for the GTML
Mouse Model
Using MM2S, we previously identified two genetically
engineered mouse models recapitulating transcriptomic
patterns of WNT and Group3 subtypes [4]. We
expanded here on MM2S predictions using 20 sample
replicates of the GTML mouse model. Using the
MM2S.mouse function, we observed the largest num-
ber of Group3 predictions across sample replicates
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Fig. 1 Overview of the MM2S package and its applications for MB subtypes of patient tumour samples and MB mouse models. A test sample (circled
black star) representing normalized gene expression from human or mouse datasets is run using either of the MM2S.human or MM2S.mouse prediction
functions, respectively. The MM2S prediction algorithm uses an ssGSEA and KNN-based approach to determine the MB subtype of a given sample, by
looking at its 5 closest MB neighbors in 3-dimensional space. A selected number of functions can render the MM2S output in terms of sample-centric
or subtype-centric views. The PredictionsHeatmap provides a heatmap representation of MM2S confidence predictions, for each sample, across all MB
subtypes (WNT, SHH, Group, Group4, as well as Normal samples). Darker colors indicate a higher confidence and greater probability that a given sample
belongs to a respective subtype. The PCARender function presents PCA plots of tested samples (purple) against the human training set (colored by
subtype). This shows, in 3-dimensional space, the nearest MB samples to a given test sample, which indicates how the finalized subtype was assigned
using the KNN algorithm. Subtype-centric views include PredictionsDistributionPie, which presents a pie charts of the major subtypes predicted across
all the samples tested. PredictionsDistributionBoxplot highlights overall strength (in terms of MM2S confidence interval) of subtype predictions that were
identified across all samples tested
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(Additional file 6: Table S3). A heatmap representation
of MM2S predictions across GTML replicates indicates
that the majority of replicates predict as Group3 with high
degrees of confidence (>80 %). This is further affirmed by
looking at the distribution of predicted subtypes, and the
predicted strengths of all the subtype calls, across all the
replicates predicted (Additional file 2: Data 1). Overall,
our analysis suggests the potential for a non-SHH mouse
model but cautions that some of the sample replicates
tested also predict as SHH or “normal-like”. These
“normal-like” samples are tumour samples that resemble
normal cerebellum more than any of the four MB
subtypes. Further investigations will need to be conducted
on these heterogeneous samples to assess their validity for
use as a Group3 mouse model.
Conclusion
We have implemented the MM2S software package for
personalized classification of individual Medulloblastoma
(MB) samples from human patients and corresponding
model systems into published human MB subtypes. We
demonstrate the relevance of MM2S to produce robust
human subtype classifications for individual human
patient samples, and for single-sample replicates of mouse
medulloblastoma models. We highlight how our package
facilitates single-sample predictions and further investiga-
tion into ambiguous genotype potentially due to tumor
heterogeneity. The overall design of the MM2S packages
makes it a flexible software tool for use by researchers,
which would facilitate and extend the use of the MM2S in
diverse computational and bioinformatics contexts.
Availability and requirements
Project Name: MM2S
Project Home Page: The R package MM2S is open
source and available on CRAN <https://cran.r-projec-
t.org/web/packages/MM2S/> under the GPL-3 License.
(Package source code is also available on Github at
https://github.com/DGendoo and https://github.com/
bhklab).




Additional file 1: Figure S1. Overall analysis design of the MM2S
algorithm. A detailed explanation of the algorithm is provided in the
Implementation section of the manuscript. (PDF 894 kb)
Additional file 2: Data 1. Vignette demonstrating installation and use
of the MM2S package, as well as the code used to reproduce the case
studies presented in the manuscript. (PDF 574 kb)
Additional file 3: Data 2. Vignette demonstrating how to obtain raw
gene expression profiles (from Microarray data) from the NCBI GEO
repository, and subsequently filter and normalize the data so that it is
ready to use in the MM2S.human or MM2S.mouse functions. (PDF 208 kb)
Additional file 4: Table S1. MB predictions for human patients of the
GSE37418 dataset. The final subgroup prediction of MM2S, per sample, is
indicated as ‘MM2S_prediction’. Sample predictions are colored by their
predicted MB subgroup as follows: Group3 (yellow), SHH (red), WNT (blue),
Group4 (green), and normal (grey). For each sample, the closest 5 human
neighbors used to make a prediction are also indicated, with percentages
indicating the abundance of each particular MB subgroup within the
neighbors. (XLSX 15 kb)
Additional file 5: Table S2. Confusion matrix of Human MB subgroup
predictions for the GSE37418 dataset. Each column of the matrix represents
the number of samples in a predicted Human MB subgroup, while each row
represents the number of subgroup-specific human samples. (DOCX 15 kb)
Additional file 6: Table S3. MB predictions for replicates of the GMTL
mouse model from GSE36594. The final subgroup prediction of MM2S,
per sample, is indicated as ‘MM2S_prediction’. Sample predictions are
colored by their predicted MB subgroup as follows: Group3 (yellow), SHH
(red), WNT (blue), Group4 (green), and normal (grey). For each sample, the
closest 5 human neighbors used to make a prediction are also indicated,
with percentages indicating the abundance of each particular MB subgroup
within the neighbors. (XLSX 12 kb)
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